News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
With Iowa losing pharmacies, lawmakers advance new rules
Bill establishes stronger requirements for pharmacy benefit managers
Why Drugs Are Disappearing From Your Insurance Coverage
Powerful companies are removing hundreds of medicines from insurance plans — and they’re spending millions to stop attempts at reform.
The U.S. pharmacy industry is crumbling. Here’s how to fix it.
An opinion piece by Robert Gebelhoff.
CVS hellth: Corporate consolidation is ruining pharmacies and hurting patients
An opinion piece by pharmacist and independent pharmacy advocate Luke Slindee.
‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
A STAT News Investigation
Commerce fines CVS Caremark $500,000 after 2022 case alleging violations of Pharmacy Benefit Manager Act
The Minnesota Department of Commerce announced it has levied a $500,000 penalty against the pharmacy benefit manager CVS Caremark after alleging that Caremark violated state law prohibiting a practice known as ‘patient steering.’
HMO profits from Minnesota state programs jump to $675.8M with enrollment surge
Enrollees used less care than expected, and a state program to cap profits was no longer in place, leading to an increase of about 181% in operating income.
NY Governor Hochul Launches New Statewide Medicaid Pharmacy Benefit Program
Long-Awaited Transition to NYRx Provides Eight Million Members Expanded Access to Prescription Medications at More Than 5,000 Pharmacies Statewide
How pharmacy deserts are formed
PBMs play a big role in the formation of a pharmacy desert.
Ozempic shortages? Some pharmacists are choosing not to stock the drug at all
Some independent pharmacies are losing money on the pricey — and popular — drug.
Documents reveal the secrecy of America's drug pricing matrix
American businesses spend hundreds of billions of dollars a year on prescription drugs, and the bills keep getting bigger. But some of the companies promising to help rein in those costs prevent employers from looking under the hood.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.